This inventor holds 2 USPTO granted patents. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1994-1997.
Company Filing History:
Years Active: 1994-1997
Title: Carol D. Katayama: Innovator in Gene Expression Regulation
Introduction
Carol D. Katayama is a prominent inventor based in Encinitas, California. She has made significant contributions to the field of gene expression regulation, holding 2 patents that showcase her innovative work. Her research focuses on the preparation and use of nucleic acid promoter fragments derived from various plants.
Latest Patents
One of her latest patents involves the external regulation of gene expression. This patent describes the preparation and use of nucleic acid promoter fragments derived from corn, petunia, and tobacco. These fragments are highly responsive to a range of substituted benzenesulfonamides and related compounds. They are instrumental in creating recombinant DNA constructions that can transform plants, allowing for the expression of desired gene products under external chemical control in various tissues of both monocotyledonous and dicotyledonous plants. Another significant patent focuses on external regulation of gene expression by inducible promoters.
Career Highlights
Carol D. Katayama is associated with E.I. DuPont de Nemours and Company, where she has been able to apply her expertise in genetic engineering and plant biotechnology. Her work has contributed to advancements in agricultural biotechnology, particularly in the development of crops with enhanced traits.
Collaborations
Throughout her career, Carol has collaborated with notable colleagues, including Howard P. Hershey and Timothy D. Stoner. These collaborations have further enriched her research and expanded the impact of her innovations in the field.
Conclusion
Carol D. Katayama is a trailblazer in the realm of gene expression regulation, with her patents paving the way for future advancements in plant biotechnology. Her contributions continue to influence the agricultural sector and enhance our understanding of genetic engineering.
